YieldMax COIN Option Income Strategy ETF vs Zoetis Inc — how do they compare? YieldMax COIN Option Income Strategy ETF trades at $19.04 (market cap $370.88M), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 81.4× YieldMax COIN Option Income Strategy ETF's market cap, and Zoetis Inc pays a 2.9% dividend while YieldMax COIN Option Income Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax COIN Option Income Strategy ETF for 41 Days and Zoetis Inc for 70 Days on average.
| CONY | ZTS | |
|---|---|---|
Market Cap | $370.88M | $30.20B |
Volume | 595,904 | 6,175,327 |
Sector | Income / Options Overlay | Health |
52-Week High | $76.50 | $147.53 |
52-Week Low | $17.73 | $69.09 |
Typical Hold Time | 41 Days | 70 Days |
Enterprise Value | — | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
CONY trades at $19.04, down 0.63% on the day, with a bearish technical signal from moving averages but bullish oscillators like RSI indicating potential oversold conditions. The ETF has experienced significant price erosion year-to-date, with a 51.3% decline noted in recent analysis, despite offering high distribution yields. Recent news highlights weekly dividend announcements and regulatory impacts on crypto-related stocks.
The outlook remains challenging due to structural NAV decay and full downside exposure to COIN. While the shift to a call spread strategy offers partial upside participation, the fund's high-risk profile and regulatory uncertainties present substantial headwinds for investors seeking stable returns.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
CONY is an actively managed ETF that seeks to generate weekly income by selling call options on Coinbase (COIN) stock. It aims to provide high yield while maintaining exposure to the price movements of the crypto exchange.
Read more on CONY →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →